GVHD: Clinical Trials

8 trials for GVHD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 recruiting, 1 terminated. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 4, Unknown 2, Recruiting 1, Terminated 1
Phase 21Completed 1

Follow GVHD: new trials by email Literature Review of GVHD trials Research Report on GVHD

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor
Grafalon, Thymoglobulin - GVHD
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris3242023-11-282026-04-27
Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis
PTCY - GVHD
Phase 3UnknownShanghai Jiao Tong University School of Medicine1382023-10-012023-08-21
Effect of PMSCs and Their Secretome for the Treatment of GvHD
Secretome (set of substances released from the cell to its surroundings) of mesenchymal stem cells retrieved from the placenta (containing 400 microgram protein/ milliliter), 4 cc distilled water dissolved in albumin 20% - GVHD
Phase 3CompletedTabriz University of Medical Sciences602023-01-012024-06-21
A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)
Itolizumab, EQ001 Placebo - Graft Versus Host Disease, GVHD
Phase 3TerminatedEquillium1582022-04-292025-06-17
Outcomes of Patients After Allo-HSCT With Decitabine and NAC
decitabine, Acetylcysteine, Semustine - Engraft Failure, Relapse
Phase 3UnknownThe First Affiliated Hospital of Soochow University1002021-07-012021-06-30
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
CD45RA-depleted peripheral blood mononuclear cells - Leukemia, Lymphoma
Phase 2 / Phase 3CompletedFederal Research Institute of Pediatric Hematology, Oncology and Immunology1502016-10-012023-03-16
Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC)
Spectra Optia - GvHD, Lung Graft Dysfunction
Phase 3CompletedFondazione IRCCS Policlinico San Matteo di Pavia512015-08-012016-01-11
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
US-ATG-F, Placebo - GVHD, Adult Acute Myeloid Leukemia
Phase 3CompletedNeovii Biotech2602011-10-102019-04-09

Narrower conditions

Graft vs Host Disease (4)  ·  Myelodysplastic Syndromes (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)  ·  Opportunistic Infections (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Broader conditions

Immune System Diseases (5)  ·  Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)

Interventions

thymoglobulin (2)  ·  Acetylcysteine (1)  ·  Antilymphocyte Serum (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Cytarabine (1)  ·  Decitabine (1)  ·  Mycophenolic Acid (1)  ·  Secretome (1)  ·  Semustine (1)  ·  itolizumab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Equillium (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Neovii Biotech (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  Tabriz University of Medical Sciences (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

Australia (2)  ·  France (2)  ·  Italy (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Germany (1)  ·  Iran (1)  ·  Israel (1)  ·  New Zealand (1)  ·  Portugal (1)  ·  Russia (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Anne Kuan (1)  ·  Babak Nejati, MD (1)  ·  Graciela Pavon-Djavid, PhD (1)  ·  Hossein Ghasemi Moghadam, MD (1)  ·  Larisa Shelikhova, PhD (1)  ·  Michael Maschan, PhD (1)  ·  Sepideh Zununi Vahed, PhD (1)  ·  Yue Han, Prof. (1)

Results publications

PMID 37341189